Размер шрифта: A A A Цвет сайта: A A A

People



 Ilya Serebriiskii



PhD
Head of the Group, Assistant Professor (h-index-21), Fox Chase Cancer Center– FCCC, USA 
Profile
e-mail: Ilya.Serebriiskii@fccc.edu

Research Interests

The main focus of my research is to improve targeted therapy for cancer, and to develop new rational strategies for combination of targeted agents. In the clinic, epidermal growth factor receptor (EGFR)-targeting antibodies or small kinase inhibitor molecules are widely used to treat patients with gastrointestinal (GI), breast, head and neck, and lung cancers. Unfortunately, the clinical efficacy of these agents is limited by intrinsic primary and acquired resistance factors.



  Igor Astsaturov


  

MD, PhD 
Assistant Professor (h-index-16), Fox Chase Cancer Center– FCCC, USA
Profile
e-mail: Igor. Astsaturov@fccc.edu

Research Interests

 - Analysis of pro-survival signaling networks and epithelial-to-mesenchymal transition, to predict effective therapeutic strategies

 - New regulators of cisplatin resistance in head and neck cancers

 - Constitutional defects in suppression of DNA double strand breaks (DSB) in familial colon cancer



  Zinaida Abramova


  Абрамова Зинаида Ивановна

PhD, DSc
Chief researcher (h-index - 3), Kazan Federal University - KFU, Russia
Profile
e-mail: Zinaida.Abramova@kpfu.ru

  Yanis Boumber


Yanis Boumber, MD, PhD  

MD, PhD

Assistant Professor (h-index-15), Fox Chase Cancer Center– FCCC, USA

Attending Physician, Hematology / Medical Oncology, Fox Chase Cancer Center– FCCC, USA

Profile
e-mail: Yanis.Boumber@fccc.edu

Research Interests

 - The main areas of my research are lung cancer, RNA-binding proteins (RBP), including Musashi-2, and their role in carcinogenesis.

 - Study of signaling pathways that regulate RBP, mechanisms for the regulation of expression of proteins dependent on RBP, and modulation of targeted therapy with RBP.

 - Transgenic model of knockout protein Musashi-2.